Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience

Safety and Efficacy of Sofosbuvir Based Regimens in Treating Chronic ‎Hepatitis C Virus in Egyptian Patients: Real World Study: Single Center ‎Experience

Efficacy, Safety and Relapse of Sofosbuvir in Combination with Daclatasvir, Ledipasvir and Simeprevir for Treatment of Hepatitis C Virus in Egypt

SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS

Efficacy of Sofosbuvir plus Daclatasvir in Treatment of Chronic HCV Infection in Egyptian Patients: A Prospective Cohort Study

Pegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients

The outcome of the sofosbuvir Based Therapy in the treatment of Hepatitis C Virus Genotype 4 in Egyptian patients

Safety and Efficacy of Direct Acting Antivirals (Sofosbuvir & Daclatasvir) in treatment of Chronic HCV in HIV-HCV Co-Infected Egyptian Patients

Impact of direct-acting antiviral therapy in Egyptian patients with chronic hepatitis C and liver cirrhosis

QUALITY OF LIFE OF CHRONIC HEPATITIS C PATIENTS RECEIVING SOVALDI TREATMENT REGIMENAT SHARQ ALMADINA IN ALEXANDERIA